Cargando…

845. Trends and Regional Differences in Community-Onset Fluoroquinolone-Resistant E. coli in Hospitalized Adults in the United States

BACKGROUND: Escherichia coli is a common cause of community-onset (CO) infections, including urinary tract and abdominal infections, and CO sepsis. Fluoroquinolones (FQ) are used in the empiric treatment of E. coli infections, but FQ-resistance may limit their effectiveness. We examined trends and r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolford, Hannah, Baggs, James, Hatfield, Kelly M, Olubajo, Babatunde, Preston, Leigh Ellyn, Kourtis, Athena P, McDonald, Clifford, Jernigan, John A, Reddy, Sujan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777371/ http://dx.doi.org/10.1093/ofid/ofaa439.1034

Ejemplares similares

1686. Microbiology of Community-Onset Urinary Tract Infections in the United States, 2012-2017
por: Preston, Leigh Ellyn, et al.
Publicado: (2020)

427. Trends in Hospital-onset Escherichia coli Infections Resistant to Fluoroquinolones and Extended-spectrum Cephalosporins, 2012-2020
por: Hood, Nicole, et al.
Publicado: (2022)

2479. Trends and Regional Differences in Extended Spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, 2012–2017
por: Wolford, Hannah, et al.
Publicado: (2019)

Temporal trends in urine-culture rates in the US acute-care hospitals, 2017–2020
por: Kazakova, Sophia, et al.
Publicado: (2022)

121. Temporal Trends in Urine Culture Rates in the U.S. Acute Care Hospitals During 2012–2017
por: Kazakova, Sophia, et al.
Publicado: (2020)

916. National Estimates of the Proportion of Bacterial Pathogens Expressing Resistant Phenotypes in US Hospitals, 2012-2017
por: Baggs, James, et al.
Publicado: (2020)

545. Incidence of Carbapenem Non-Susceptible Acinetobacter spp. and Carbapenem-Resistant Pseudomonas aeruginosa Clinical Cultures among Patients in US Acute Care Hospitals, 2012–2017
por: Kazakova, Sophia, et al.
Publicado: (2019)

2455. National Trends in the Rates of Drug-resistant Bacteria Commonly Associated with Healthcare in U.S. Acute Care Hospitals, 2019-2021
por: Baggs, James, et al.
Publicado: (2023)

24. Antibiotic Use in Hospital Emergency Departments and Observation Settings from 2012–2018 in a Large Cohort of U.S. Hospitals
por: Preston, Leigh Ellyn, et al.
Publicado: (2020)

2850. Burden of Difficult-to-Treat Antibiotic-Resistant (DTR) Gram-Negative Infections in the United States, 2012–2017
por: Kadri, Sameer S, et al.
Publicado: (2019)

2472. Hospital Onset Antibiotic Resistant Infections among Patients without COVID-19 Diagnosis in Pre-Pandemic and Pandemic Periods
por: Baggs, James, et al.
Publicado: (2023)

1428. The proportion of excess hospital-onset antibiotic-resistant infections attributable to patients diagnosed with COVID-19 in U.S. hospitals, 2019-2021
por: Wolford, Hannah, et al.
Publicado: (2023)

2463. Increased Rates of Candida Bloodstream Infections Associated with Drug Use, United States 2012–2017
por: McCarthy, Natalie, et al.
Publicado: (2019)

Association of Hospital-Onset Clostridium difficile Infection Rates and Antibiotic Use in US Acute Care Hospitals, 2006–2012: An Ecologic Analysis
por: Kazakova, Sophia, et al.
Publicado: (2017)

Associations of facility-level antibiotic use and hospital-onset Clostridioides difficile infection in US acute-care hospitals, 2012–2018
por: Kazakova, Sophia V., et al.
Publicado: (2022)

Assessment of Hospital-Onset SARS-CoV-2 Infection Rates and Testing Practices in the US, 2020-2022
por: Hatfield, Kelly M., et al.
Publicado: (2023)

2891. Trends in Inpatient Antibiotic Use in US Hospitals, 2012–2017
por: Baggs, James, et al.
Publicado: (2019)

2473. Rates of Antibiotic Resistant Infections in Hospitalized Patients with Hematologic and Non-Hematologic Cancers, 2019
por: McCarthy, Natalie, et al.
Publicado: (2023)

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States
por: Kourtis, Athena P., et al.
Publicado: (2019)

Length of antibiotic therapy among adults aged ≥65 years hospitalized with uncomplicated community-acquired pneumonia, 2013-2020
por: McCarthy, Natalie, et al.
Publicado: (2023)

Empiric antibiotic selection for community-acquired pneumonia in US hospitals, 2013–2020
por: Wolford, Hannah, et al.
Publicado: (2023)

Fluconazole resistance in non-albicans Candida species in the United States, 2012-2021
por: Jenkins, Emily, et al.
Publicado: (2023)

558. Evaluating Length of Stay Data for Use in Targeting Prevention of Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections
por: Gouin, Katryna, et al.
Publicado: (2019)

Rapid evolution of fluoroquinolone-resistant Escherichia coli in Nigeria is temporally associated with fluoroquinolone use
por: Lamikanra, Adebayo, et al.
Publicado: (2011)

519. Longer Length of Antibiotic Therapy for Community-Acquired Pneumonia and Risk of Clostridium difficile Infection
por: Yi, Sarah H, et al.
Publicado: (2018)

2314. Hospitalizations and Antibiotic Use in the Year Prior to an Incident C. difficile Infection for Medicare Beneficiaries in Four States, 2016–2018
por: Hatfield, Kelly M, et al.
Publicado: (2022)

Declines in the utilization of hospital‐based care during COVID‐19 pandemic
por: Kazakova, Sophia V., et al.
Publicado: (2022)

Cellular Functions Regulated by Phosphorylation of EGFR on Tyr845
por: Sato, Ken-ichi
Publicado: (2013)

2481. Comparing inter-hospital patient movement patterns to better understand mechanisms for regional dissemination of carbapenem-resistant Enterobacteriaceae
por: Wolford, Hannah, et al.
Publicado: (2019)

Trends in Antibiotic Use in United States Hospitals During the Coronavirus Disease 2019 Pandemic
por: Rose, Ashley N, et al.
Publicado: (2021)

287. The Attributable Mortality of Prosthetic Joint Infection After Primary Hip and Knee Arthroplasty Among Medicare Beneficiaries, 2005–2012
por: Slifka, Kara Jacobs, et al.
Publicado: (2018)

2467. Inferring Strain Type Attribution from Antibiotic Resistance Profiles among E. coli Causing Healthcare-Associated Infections in the United States, 2013–2017
por: Kourtis, Athena P, et al.
Publicado: (2019)

Leading causes of cardiovascular hospitalization in 8.45 million US veterans
por: Krishnamurthi, Nirupama, et al.
Publicado: (2018)

Correction: Leading causes of cardiovascular hospitalization in 8.45 million US veterans
por: Krishnamurthi, Nirupama, et al.
Publicado: (2018)

845. Impact of the COVID-19 Pandemic on Routine HIV Screening in an Emergency Department
por: Aguilera, Elizabeth A, et al.
Publicado: (2021)

Fluoroquinolone-resistant Escherichia coli, Indonesia
por: Kuntaman, Kuntaman, et al.
Publicado: (2005)

Nonantibiotic Effects of Fluoroquinolones in Mammalian Cells
por: Badal, Sujan, et al.
Publicado: (2015)

High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli
por: Rattanaumpawan, Pinyo, et al.
Publicado: (2017)

147. Opportunities for Improving Urine Culturing Practices in U.S. Acute Care Hospitals, 2017-2020
por: Asonganyi, Nyawung, et al.
Publicado: (2023)

Analysis of fluoroquinolones in dusts from intensive livestock farming and the co-occurrence of fluoroquinolone-resistant Escherichia coli
por: Schulz, Jochen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mea1318uho4rjom27d7jk6k8nb